<SEC-DOCUMENT>0001493152-25-009452.txt : 20250307
<SEC-HEADER>0001493152-25-009452.hdr.sgml : 20250307
<ACCEPTANCE-DATETIME>20250306204919
ACCESSION NUMBER:		0001493152-25-009452
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250306
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250307
DATE AS OF CHANGE:		20250306

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			bioAffinity Technologies, Inc.
		CENTRAL INDEX KEY:			0001712762
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				465211056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41463
		FILM NUMBER:		25717313

	BUSINESS ADDRESS:	
		STREET 1:		3300 NACOGDOCHES ROAD
		STREET 2:		SUITE 216
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78217
		BUSINESS PHONE:		210-698-5334

	MAIL ADDRESS:	
		STREET 1:		3300 NACOGDOCHES ROAD
		STREET 2:		SUITE 216
		CITY:			SAN ANTONIO
		STATE:			TX
		ZIP:			78217
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:BIAF="http://bioaffinitytech.com/20250306">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_BIAF_bioaffinitytech.com_20250306 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20250306_20250306 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001712762 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000004" name="dei:EntityCentralIndexKey">0001712762</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="biaf-20250306.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-03-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-06</xbrli:startDate>
        <xbrli:endDate>2025-03-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue0.007PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-06</xbrli:startDate>
        <xbrli:endDate>2025-03-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001712762</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-03-06</xbrli:startDate>
        <xbrli:endDate>2025-03-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_90C_edei--DocumentType_c20250306__20250306_zR1n9rVu9go2"><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Report (Date of earliest event reported): <span><b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20250306__20250306_zbLkkqrmC4L9"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">March 6, 2025</ix:nonNumeric></span></b></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_909_edei--EntityRegistrantName_c20250306__20250306_ztjV3jTPwgf8" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000011" name="dei:EntityRegistrantName">bioAffinity
Technologies, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250306__20250306_z3S6vfGbOs43"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span id="xdx_901_edei--EntityFileNumber_c20250306__20250306_zB3nb8ISNQge" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000013" name="dei:EntityFileNumber">001-41463</ix:nonNumeric></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20250306__20250306_zFNCRbjYrZsh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-5211056</ix:nonNumeric></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State
                                            or other jurisdiction</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of
    incorporation)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File
    Number)</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S.
                                            Employer</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification
    Number)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_908_edei--EntityAddressAddressLine1_c20250306__20250306_z6nfWS61NE15" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000015" name="dei:EntityAddressAddressLine1">3300
Nacogdoches Road</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_909_edei--EntityAddressAddressLine2_c20250306__20250306_zsDFAFMWpKM"><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite
216</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_907_edei--EntityAddressCityOrTown_c20250306__20250306_zN8wdrP2AnK7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000017" name="dei:EntityAddressCityOrTown">San
Antonio</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_902_edei--EntityAddressStateOrProvince_c20250306__20250306_zLGPc3vOr4Ph"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Texas</ix:nonNumeric>
</span></span></b><b><span id="xdx_90F_edei--EntityAddressPostalZipCode_c20250306__20250306_zpmW6lvlcIx4" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000019" name="dei:EntityAddressPostalZipCode">78217</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Address
of principal executive offices, including zip code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span id="xdx_909_edei--CityAreaCode_c20250306__20250306_zK3UMgdGre78" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000020" name="dei:CityAreaCode">(210)</ix:nonNumeric>
</b></span><b><span id="xdx_902_edei--LocalPhoneNumber_c20250306__20250306_zJUOcuha4WR1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" id="Fact000021" name="dei:LocalPhoneNumber">698-5334</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant&#8217;s
telephone number, including area code)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Former
name or former address, if changed since last report)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 1.5pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_904_edei--WrittenCommunications_c20250306__20250306_znuRLFTtyRAh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_edei--SolicitingMaterial_c20250306__20250306_zmtwHUdTp42a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--PreCommencementTenderOffer_c20250306__20250306_zwmaC1MLT6sk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20250306__20250306_zGtv1d7SCYD9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title
    of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trading
    Symbols</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_90B_edei--Security12bTitle_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.007PerShareMember_zvuaHBzDhBHd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember" id="Fact000026" name="dei:Security12bTitle">Common
                                            Stock, par value $0.007 per share</ix:nonNumeric></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_90F_edei--TradingSymbol_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.007PerShareMember_z5pSwyA3NVp9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember" id="Fact000027" name="dei:TradingSymbol">BIAF</ix:nonNumeric></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_909_edei--SecurityExchangeName_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--CommonStockParValue0.007PerShareMember_zH4YpwfQ2Qf5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The
                                            Nasdaq Stock Market LLC</ix:nonNumeric></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_906_edei--Security12bTitle_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zgGIvMiVtXZd" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember" id="Fact000029" name="dei:Security12bTitle">Warrants
    to purchase Common Stock</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_edei--TradingSymbol_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zfN1VnVAOAr5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember" id="Fact000030" name="dei:TradingSymbol">BIAFW</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_903_edei--SecurityExchangeName_c20250306__20250306__us-gaap--StatementClassOfStockAxis__custom--WarrantsToPurchaseCommonStockMember_zg5hivdlxzI" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">The
                                            Nasdaq Stock Market LLC</ix:nonNumeric></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Nasdaq
    Capital Market)</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_909_edei--EntityEmergingGrowthCompany_c20250306__20250306_zND63M7BZNZa"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleantrue" id="Fact000032" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_901_edei--EntityExTransitionPeriod_c20250306__20250306_zOBMduInLzaf"><ix:nonNumeric contextRef="AsOf2025-03-06" format="ixt:booleanfalse" id="Fact000033" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01. Regulation FD Disclosure.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2025, bioAffinity Technologies, Inc. (the &#8220;Company&#8221;) issued a press release announcing that it was implementing
targeted actions to deliver approximately $4.0 million in cost savings at its subsidiary, Precision Pathology Laboratory Services (&#8220;PPLS&#8221;),
while increasing resources that support continued sales growth for CyPath&#174; Lung, the Company&#8217;s noninvasive test for early-stage
lung cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to achieve the majority of the cost savings on an annual run-rate through: (i) decreased labor cost reductions, including
an approximately 38% workforce reduction at PPLS; (ii) operational efficiency enhancements, such as reduced direct costs for purchased
services and supplies; and (iii) a focus on high-margin services by discontinuing certain pathology services with suboptimal profit margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information in this Item 7.01 and in the press release furnished as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed
to be &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended and shall not be incorporated by reference
into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless
of any general incorporation language in such filing. The press release furnished as Exhibit 99.1 to this Current Report on Form 8-K
includes &#8220;safe harbor&#8221; language pursuant to the Private Securities Litigation Reform Act of 1995, as amended, indicating
that certain statements contained therein are &#8220;forward-looking&#8221; rather than historical.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
8.01. Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 6, 2025, the Company issued a press release announcing that it was implementing targeted actions to deliver approximately $4.0
million in cost savings at its subsidiary, PPLS, while increasing resources that support continued sales growth for CyPath&#174; Lung,
the Company&#8217;s noninvasive test for early-stage lung cancer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to achieve the majority of the cost savings on an annual run-rate through: (i) decreased cost reductions, including an
almost 38% workforce reduction at PPLS; (ii) operational efficiency enhancements, such as reduced direct costs for purchased services
and supplies; and (iii) a focus on high-margin services by discontinuing certain pathology services with suboptimal profit margins.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01. Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 26.2pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
    Number</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; vertical-align: top; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press
    Release issued by bioAffinity Technologies, Inc., dated March 6, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->-</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    March 7, 2025</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BIOAFFINITY
    TECHNOLOGIES, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Registrant)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Maria Zannes</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maria
    Zannes</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President
    and Chief Executive Officer</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->-</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJx1kUFuwjAQRU/AHUZRlyg4qULV7NqIoqqhigDRbk0YikXiicYOhSP1lnUcECxay5I1mv/+n5GDYBhM6UVVyPD5PM9hiXVTSYswxy0y6hKdInt9S8G9c/xSxrLU1pcXMCPHoGOSME7WruGlB2Vwk4K4H4nxKE5AjNPkEYpZMOj6Gemt2qC2SlYg9QYKpoYVWsmn3mEpj6SpPvmoFbJRpFOIQtG3fyAWUQzvdJDfxHsDeZ4Fg6E/g2DK1DZONTla1B0JkwprF2d6+nr9NGVrLNXph+RuObOkouVyJw261WrSC0vlfob1GtmJIxHHkXg6z3FhwBI0Zwp6DDz3R86NayF5JasWRSjEQ4G82EnGf6JuXYfQSIZDh8Kdh6FxX2E6/JL4CztjjwY= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: right; margin-top: 0; margin-bottom: 0"><B>Exhibit 99.1</B></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 49%; text-align: left"><IMG SRC="ex99-1_001.jpg" ALT="" style="width:250px"></TD><TD STYLE="width: 2%"></TD><TD STYLE="vertical-align: middle; text-align: right; width: 49%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>News
                                                                                                                              Release</B></FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR STYLE="clear: both"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath<sup>&reg;</sup> Lung Sales Growth</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Proactive
    steps reinforce bioAffinity Technologies&rsquo; laser focus on accelerating CyPath<sup>&reg;</sup> Lung sales growth in strategic national markets</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Decreases
    labor and overhead costs, including 38% workforce reduction in non-CyPath<sup>&reg;</sup> Lung personnel at Company&rsquo;s subsidiary laboratory</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SAN
ANTONIO, Texas (March 6, 2025) &ndash; <U>bioAffinity Technologies</U>, Inc. (Nasdaq: BIAF; BIAFW), </B>a biotechnology company focused
on the need for noninvasive tests for the detection of early-stage lung cancer and other lung diseases, today announced targeted strategic
actions to improve financial performance and accelerate the commercial growth of <U>CyPath<sup>&reg;</sup> Lung</U>, the Company&rsquo;s noninvasive
test for early-stage lung cancer. The Company expects these measures to deliver approximately $4 million in annual cost savings at its
subsidiary Precision Pathology Laboratory Services (PPLS), while increasing resources to expand CyPath<sup>&reg;</sup> Lung sales in high-potential
national markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Following
our acquisition of PPLS, we embarked on a deliberate and strategic review as part of our commitment to optimizing operations and accelerating
CyPath<sup>&reg;</sup> Lung sales. We believe our changes at PPLS support and enhance bioAffinity&rsquo;s commercial strategy to fast-track market
expansion and sales of CyPath<sup>&reg;</sup> Lung while continuing to provide PPLS clients with exceptional anatomical pathology services as it
has done for more than 25 years,&rdquo; bioAffinity President and CEO Maria Zannes said. &ldquo;We will continue to rely on the combined
innovation and expertise of both bioAffinity and PPLS employees to achieve our planned 2025 milestones, including starting enrollment
for the FDA pivotal trial for CyPath<sup>&reg;</sup> Lung and development of additional noninvasive diagnostics, including tests for COPD and asthma.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specifically,
bioAffinity Technologies expects to achieve the majority of the $4 million in cost savings on an annual run rate through:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor
    cost reductions, including an approximately 38% workforce reduction at PPLS;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</FONT></TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operational
    efficiency enhancements, such as reduced direct costs for purchased services and supplies; and,</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    focus on high-margin services by discontinuing certain pathology services with suboptimal profit margins.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With
year-over-year sales growth, CyPath<sup>&reg;</sup> Lung remains the focal point of bioAffinity&rsquo;s commercial strategy. &ldquo;Although these
actions are expected to result in a decrease in revenue, they are also expected to improve profitability at our PPLS subsidiary by focusing
on CyPath<sup>&reg;</sup> Lung and other high-value service lines,&rdquo; bioAffinity Chief Financial Officer Michael Edwards said.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Our
strategic adjustments today enhance our readiness to serve the market for noninvasive lung cancer detection in both civilian and military
healthcare systems, and we continue to see increasing sales as more and more physicians incorporate CyPath<sup>&reg;</sup> Lung into their protocol
for patients at high risk for lung cancer,&rdquo; Maria Zannes, President and Chief Executive Officer, said. &ldquo;With CyPath<sup>&reg;</sup>
Lung now available for purchase through the Federal Supply Schedule, we intend to launch a focused government marketing program next
quarter to introduce the test to Veterans Administration and Department of Defense medical centers.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
CyPath<sup>&reg;</sup> Lung</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CyPath<SUP><sup>&reg;</sup> </SUP>Lung
uses proprietary advanced flow cytometry and artificial intelligence (AI) to identify cell populations in patient sputum that
indicate malignancy. Automated data analysis helps determine if cancer is present or if the patient is cancer-free.
CyPath<SUP><sup>&reg;</sup> </SUP>Lung incorporates a fluorescent porphyrin that is preferentially taken up by cancer and
cancer-related cells. <U>Clinical study results</U> demonstrated that CyPath<SUP><sup>&reg;</sup></SUP> Lung had 92% sensitivity,
87% specificity and 88% accuracy in detecting lung cancer in patients at high risk for the disease who had small lung nodules less
than 20 millimeters. Diagnosing and treating early-stage lung cancer can improve outcomes and increase patient survival. For more
information, visit <U>www.cypathlung.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
bioAffinity Technologies, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">bioAffinity
Technologies, Inc. addresses the need for noninvasive diagnosis of early-stage cancer and other diseases of the lung and broad-spectrum
cancer treatments. The Company&rsquo;s first product, <U>CyPath<SUP><sup>&reg;</sup></SUP> Lung</U>, is a noninvasive test that has shown high sensitivity,
specificity and accuracy for the detection of early-stage lung cancer. CyPath<SUP><sup>&reg;</sup></SUP> Lung is marketed as a Laboratory Developed
Test (LDT) by <U>Precision Pathology Laboratory Services</U>, a subsidiary of bioAffinity Technologies. For more information, visit <U>www.bioaffinitytech.com</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this press release constitute &ldquo;forward-looking statements&rdquo; within the meaning of the federal securities laws.
Words such as &ldquo;may,&rdquo; &ldquo;might,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;continue,&rdquo; &ldquo;predict,&rdquo; &ldquo;forecast,&rdquo; &ldquo;project,&rdquo;
&ldquo;plan,&rdquo; &ldquo;intend&rdquo; or similar expressions, or statements regarding intent, belief, or current expectations, are
forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements
regarding the measures to deliver approximately $4 million in cost savings at Precision Pathology Laboratory Services (PPLS), while increasing
resources to expand CyPath<sup>&reg;</sup> Lung sales in high-potential national markets; changes at PPLS supporting and enhancing bioAffinity&rsquo;s
commercial strategy to fast-track market expansion and sales of CyPath<sup>&reg;</sup> Lung while continuing to provide PPLS clients with exceptional
anatomical pathology services as it has done for more than 25 years; continuing to rely on the combined innovation and expertise of both
bioAffinity and PPLS employees to achieve planned 2025 milestones, including starting enrollment for the FDA pivotal trial for CyPath<sup>&reg;</sup>
Lung and development of additional noninvasive diagnostics, including tests for COPD and asthma; achieving the $4 million in cost savings
on an annual run rate through labor cost reductions, operational efficiency enhancements and focus on high margin services; the actions
resulting in a decrease in revenue and improvement in profitability; the continued increase in sales; and launching a focused government
marketing program next quarter to introduce the test to Veterans Administration and Department of Defense medical centers. These forward-looking
statements are subject to various risks and uncertainties, many of which are difficult to predict, that could cause actual results to
differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important
factors that could cause actual results to differ materially from current expectations include, among others, the targeted actions having
the desired results, including a $4 million cost savings and improvement in profitability, the ability to increase market expansion;
the ability to start enrollment for the FDA pivotal trial for CyPath<sup>&reg;</sup> Lung and development of additional noninvasive diagnostics
in 2025; and the other factors discussed in the Company&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2023, and
its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. Such forward-looking statements are
based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions. While
the Company believes these forward-looking statements are reasonable, readers of this press release are cautioned not to place undue
reliance on any forward-looking statements. The information in this release is provided only as of the date of this release, and the
Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release,
except as may be required by applicable securities laws.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>bioAffinity
Technologies</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Julie
Anne Overton</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director
of Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jao@bioaffinitytech.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dave
Gentry</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RedChip
Companies Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1-800-RED-CHIP
(733-2447) or 407-491-4498</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>BIAF@redchip.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $! F@# 2(  A$! Q$!_\0
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MQ2V%NB:E>E?[9Z$[I/N2U9V/X9?^#DK]EWXA>#_VKM'_ &H8],OM3^%_Q?\
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MND6&0SV;RF26&.WFA:0Q>0D:OK;\1V/TBHHHIB"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BJFH:A8Z387VJ:G>6VGZ;IMG<ZAJ%_>31V]I8V-G"]S=W
MEU<2LL4%M;6\<DT\TC+'%$C.[!5)'\3_ .W;_P '2/Q*TSXG^(/ ?[#'@/P
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M@6+6[R\6_N+;0]?^('ACPS)<JYD)'@OPWXNTKP?%#(Y)EM8M"CM91A9(655
M37Z?@[E1E96:VOMYG\K'_!M[^R%\0/B?^V/I/[3]QH6HV/PH^ &D^*)5\53P
M20:=J_Q!\4>&[[PGIGAG39I%6._N+;1=?UG5M5^SM)_9L<%@MR$;4+;=_?E7
M%?#WX;^ /A+X1T?P#\,/!GAGX?\ @G0(/LVB^%?".C6&@Z%IL).YQ;:=IT%O
M;(\KDR3S%#-<2LTL\DDK,Y[6A*R2)D[NX4444Q!1110 4444 %%%% !1110
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M$%LDU!<))73^\_BZ3[Z_[P_G7^M)_P $SH?&=M_P3W_8PM_B$E]'XPA_9O\
MA-%K,>J"1=3C9/"&F+9)J0F_?_V@NG"S6],Y,[70E:8F4N3_ #2_L%_\&N6O
M^%OB/X6^)?[</Q"\':YX8\+ZA9ZVOP5^'<E_J\7BG4+"83V^F>,O%-_9Z;:Q
M>&WF6)]0T_1K:[N=6@CET^6[LK>XDD/]FUM;P6=O!:6L,=O:VL,5O;6\*+'#
M!! BQ0PQ1J J1Q1JJ(B@*JJ%   H%-IO3L34444$A1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*Q&'K*%:E-TZTU&K3DU./\UG_$2?^V3_ -$M^ ?_ ((O&?\ \VM?U7_L!_M
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MPF_N[>VVPSR3;Y5/E[,L&K75]NHU:ZOMU/F__B+._8]_Z-K_ &D/^_OPS_\
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MO^NB_4.6*W=W_71?J;?@[_@[(_:VTR]63QS^SG\"?%NG^<C/::%?^-?!UT8
M )(TO;C4_%4:RM\Q29[*1$)&Z"0 AOW)_8:_X.-_V+_VK]?T7X=?$ZWU;]F/
MXG:W-9:?I=O\0-1L+[X=Z[J]V4A6QTOQ_;"UMM.EFNY8K6RC\4:?H?VN60)%
M*S#!_CX_;._X(@?\% /V(O#6H_$'X@?#?2OB%\+=(0SZS\2?@YK$_C30?#UJ
M7=5NO$^F3Z;HWBS0;)556N=6O?#HT&T:2**?5UDDC5_R*Y![@@_B#3Y8M:?@
M_P [CY8M:?@_SN?[1D<D<T<<L4B2Q2HLD4L;*\<D;J&22-U)5T=2&5E)5E((
M)!!I]?R#_P#!M=_P53\2_%:WG_8%^/?B2[U[Q;X2\.W>O_L_>+M:O'N=3UCP
MAH,2-KOPVU"]NY6FO;SPO8%=7\*L6FN7\.6^KV4A2WT*T,G]?%9M6=F9M6=F
M%?&7[>W[:O@?_@G_ /LZ:[^TC\1/"/BWQOX8T#Q%X7\.7.@^"FT9==EN/%6I
MKIEI=1'7=1TO3_LUK*PEN@UT)O*SY,4K_+7V;7X(?\'*7_**WXE_]E-^$'_J
M61T+5I>:!:M+S1\>C_@[-_8]) _X9L_:0Y('^M^&?<_]CC7])?[.WQJT3]HW
MX&?"KX[^&]'U?P]H/Q8\$Z'XXTG0]?-BVM:58Z[:K=P66IG3;J]L#>0(X28V
MEW<0;@?+E<<U_CKI]]?]Y?YBO]9O_@EU_P H[OV-?^R ?#[_ -,\-5**25BI
M122L?5GQA^)6F?!KX4_$;XLZSIVH:OI'PW\%^(_&VI:5I)M1JFHV/AO2KG5K
MFST\WL]M9B\N(;5XK<W5Q!!YK+YLJ)EA_,J?^#LW]CT$C_AFS]I#@D?ZWX9]
MC_V.-?T5_M;>$/$GQ _9>_:#\#>#M*FUSQ7XN^#OQ"\.^'-&MY((9]4UK5_#
M&I6.FV$,MS+#;QR75W-%"CSS11*S@R.J@D?YK[?\$+?^"KI9B/V-_'N"21_Q
M4?PW'!/OXUS1%1=[O\;!%1=[O\;'<_\ !:G_ (*7_"O_ (*:?&#X0_$;X5_#
M_P ?_#_3OAW\/-3\':K9>/Y/#SWFH7U[XAGUB*[T\>'M3U2%+6.WE6&07,ZR
MF8%E0)BOSM_8\^-.@?LY_M3_ +/_ ,>/%.D:OK_ASX1_%?P7X^UO1- >SCUK
M5--\-:U:ZG=V.ER:A)#8I?7$,#1V[7<L< D93*ZKDBQ^TW^QS^TI^QMXD\.^
M$?VEOA5K7PI\1>+-&F\0>'M,UJ_T"_FU/1[>[:PFOH9- U;5[=(X[M&@9)IH
MI=ZG$949KQOX<?#OQG\7/'OA'X8_#K0KGQ/X[\>:_IOA?PEX=LY;6"ZUK7M8
MN4L]-TZWFOKBULXYKJYD2*-[FY@A#,-\J#FM+*UNEN_3U-+*UNEN_3U/[J?^
M(L[]CW_HVO\ :0_[^_#/_P";&C_B+._8]_Z-K_:0_P"_OPS_ /FQK^8H_P#!
M"S_@J\"1_P ,;^/>#CCQ)\-B/P(\;8(]Z/\ AQ;_ ,%7O^C-_'O_ (4?PV_^
M;:IY8=_Q)Y8=_P 3_0-_:V_X*-^#?V2/V/? /[:'B'X1_$KQW\./&EA\.=4O
M]%\'2^%_^$D\':=\3-!@UG0KS7X]6UJQL)+>"YN[/1+Z73;N\2+4;NW*EK5_
M/'XS_P#$6=^Q[_T;7^TA_P!_?AG_ /-C7[D:[^R[%\<O^"=.E_LF_$_3?[)U
M#Q3^RSX,^&.OV5W)%))X;\8Z9\/-%L+>>2:U-S$T_ASQ7I]M<M+:/,CO8L8)
M'5E8_P"4;\1_ 7B'X6^/_&GPV\6V4NF^)_ GBC7?"6OV,\;12VNK>']2N=+O
MHF1\L MS:R;220R;6!(()F*3O??U)BD[WW]3_6C_ &'?VR?AK^WG^SGX0_:0
M^%=AK6B^'/%-]K^DW7ASQ(=//B'PWK7AS5KC3+W2M8.E7=_IWVEX8[35(?LM
MW,AL=2LS(4F,D4?US7\3W_!I_P#M51V>M_'_ /8Z\0:FP_MJULOC5\.K.YNY
M77[9I2VWASQY8Z?:$&.$SV,_AO5)V5E$@L)F8!^9/[8:EJS:):LV@HHHI""O
MP_\ ^"B'_!=O]FK_ ()U?'.P^ 'C[X<_%'XE^,Y?!.C>-M7G^'C^$?[-\.V^
MOWFJ6^EZ/JCZ_K^EW"ZQ-::8-5>WB@=(M.U#39FD)N@J_M7KVN:3X8T/6?$N
MOW]OI6A>'M*U'7-:U.[?9:Z=I.DV<U_J5_<O@[+>SL[>:XF?!VQQL<'%?Y''
M[=G[26J_M=_M=_'[]HC5'F\KXD_$36]2\/VLSL[:9X-T^1-$\$Z2N20O]F>$
M],T>SDV!5DGBEF*[Y6)J*N]=OZL5%7>NW]6/[D_V=/\ @Y7_ &>/VGOCI\*_
MV?OAI^S#^T7=>-OBSXTT7P=HC7,WPW%CIYU.Y4:AKNJ/%XO>6/1O#FE)?:_K
M4L,<LT.E:;>2PPS2HD3E?DG_ ,&JO[("^-/C7\6_VR/%&E";1/@_HW_"M/AQ
M<W"120MX_P#&=JMSXGU*V61?-CN]!\'B'3X[B$E#'XNN8V(=%HHDDG9= DDG
M9=#^[6OY+O\ @YX_X^?V2O\ KT^+'_I1X%K^M&OY+O\ @YX_X^?V2O\ KT^+
M'_I1X%KX7Q&_Y(_-?\6!_P#4_#G]Q_LWO^4R/";_ *]\<?\ K!\1'\G%?UR?
M\$ ?^"<'AU_#EK^W'\9?#MOJVLWVH7EG\ ="UBT,MKHUIIDS6>I_$UK6Y7RI
M=6NM0CN=*\)SO$PTVWLKW6K5FN+_ $ZXL_Y/_!OAN\\8^+O"_A+3L?VAXG\0
M:/X?L=REU^V:QJ%OI]MN4%2R^=<)E0P)&0""17^I=\(/AYHWPE^%7PY^&/AZ
MQ@TW1? /@KPWX3T^QME"P00:'I-K880#@EY(7D=OXW=F/+5^7^%V14,RS;$Y
MEBJ<:M'*(494*<XJ4)8[$2G[&I*+34GAJ5*=:"::565.=FZ<;?ZG_M4O';/?
M#7PEX:\-.%<PQ&59MXO8W.,/GN88.O/#XVCP/P_0P:S?+\/6I2IUJ,>(LSS3
M Y1CJM*I3G+*L-F&#YU3S'$JKZ-1117]$'_.6%?SM?\ !?'_ ()_>'_C'\%=
M1_:V^'^A0VOQ?^#FG02^.IK"%4E\;_"ZV?R[M]252HGU3P1YIU2PO2#.="_M
M;3Y?/6/319_T2US7C/POIGC?PAXI\&:U;PW>D>+/#VL^'-3MIXUEAFL=:T^X
MTZZCDC8,K*T-PX((/MS7D9[E&'SS*L9EN)A&4<11G[&;2<J&)A&4L-7IMZQG
M2K*#NFKPE4@[QFT?KO@1XN\1>!GBOP9XE\.8O$4*V09Q@WF^$HUITZ.=\,XK
M$X;#\1Y#CJ<9<F(PF:9//&4_9U85(TL;0RW&TU#$8*C5C_E&C*GW!Z?3L?ZU
M_H9?\$5?VE+[]I#]@SX;S^(;]M0\9_"&[OO@WXFN9Y?,N[R+PE;V,_A/4KC>
M\DSO<^#-3T&VN+N8EKS4K#49L[MX7^ ?XI>$F\ _$OX@^!79V?P9XV\4^%7:
M3'F,_A_6[[27,F/EWE[1MX7@-D#@5_4;_P &QOQ F%Q^U/\ "V6</!-:?#OQ
M[9V[2G=;RVD_B'P]J4T,6_ 6Z2^TE+APG6SM@6&<-^!>&F.JX#BNG@Y-QAF%
M#%X&O3OI[:A&I7HMK9RIUL-6A%VO:<EHFT?] W[3G@?*N/OHG8_C/#TJ>(QO
MA_G?"7'&18]4X^V63Y_6P.19Q3C-<TH4,=DW$N3XJM3YW#VF"H2?-4IPDOZT
M*_.#_@KI_P HY/VJ/^Q"L_\ U*= K]'Z_.#_ (*Z?\HY/VJ/^Q"L_P#U*= K
M]]X@_P"1#G?_ &*,S_\ 4'%'_/Y]'O\ Y/YX(?\ 9W_#+_UNN%S_ #AJ_P!%
M_P#X(U?\HT/V5_\ L6O&W_JUO'E?YT%?Z+__  1J_P"4:'[*_P#V+7C;_P!6
MMX\K\1\)/^2@S#_L3U/_ %.PA_N-^UZ_Y1[\/O\ L\F7_P#K"\6'Z<U\R?MD
M?M%:5^RC^S1\7/CQJ<<%S/X&\*W=QX>TV=T1-8\6ZB4TOPMI;!Y(M\5UK=W9
M?:U1Q*+%+J2/+(!7TW7\U_\ P<I_%FZ\._LZ_!?X16%UY0^(?Q&O_$>M6P!S
M/I?@O2?+L@2&' U37HI<,K+NM@<!PC+^T<39G+)\@S7,:;2K8?"5/J[=G;$U
MG'#X=V>CY:M>-2VM_9ZZ7/\ %'Z,/AAAO&7Q_P#"GPXQ].53)^(N+L ^((0E
M*+GPYD\,3Q!Q!2YXM2I_6<JR3$8'GC*,H_VDW"4:BIL_CE\?>.?$_P 3/&OB
MKX@^--7N]>\5^,M>U3Q)X@UB_E>:[U'5M7O);V]NII'+$M+/,[!0=L:[8T"H
MBJ/Z/_\ @@M_P34\/_%_49_VPOCCX>M=;\#>#];_ +,^$7A/5[<3Z;XB\8Z5
M(LNH^+-4LY5,-]I?A>?[+!I5M,LEK=ZXUQ+/$PTA5E_FCTC3I]7U73=*M4\R
MYU&^M;&WCY/F3W4R0Q)P"?G=U7@$\\ GBO\ 4)_97^#.E_L]?LY_!GX,Z5:1
MV<7@'X?^'=&U!(U"^?KYL8[SQ+?.,!C+J'B"YU*]D+Y?=.0S,1D_AOAKD5+.
ML[KX_'0^L8?*X0Q+C5]^-?'XBK-T'6Y^95%3<*V*E&?,IU%3<U)1:?\ NM^T
MS\=LT\%/!#A_P_X$Q3X>S[Q3Q6,X9IXK*7]0KY%P#P[E>#AGU'*'A7AY9?+,
M(8K)N%L/5PCH2P>65,QI8:="=:%2'OH         &  .  !P !P .E+117]'
MG_-B%>2_''X'_#3]HSX7^*_@_P#%SPS9>*O!'B_3Y++4+"Z11<6=QM;[%K.C
MW>TS:9KFDW!6\TO4K9DGM;B,$%HFEBD]:HK.K2IUZ=2C6IPJT:L)4ZM*I&,Z
M=2G.+C.$X23C*,HR:::::?HUW97FF99)F67YSD^/QF59ME6-PN8Y9F>7XFM@
M\?E^/P5>EB<)C,'B\/4I5\/B<-B*-*K1K4JD9PG!;QE.%3_,7_;;_95\5?L9
M_M)?$7X#>)WGOH/#>I"]\(^(98?)C\5^"-7!O/#'B&)0J1^9=6#"UU*.(&*T
MUJRU.QC9Q:[V^\/^"%W[5M_^SO\ ML>$_ NIZE)!\._VB#;?"[Q+922*ME#X
MFO)GE^'FN%6(5;NV\1R#05ER ECXEOC)D*I3]-O^#FCX,6(L?V<OV@;.V@AO
MVO/$7PFUZY1%%Q>PO;GQ7X:6=MNYTL?LWB40G=A?MDBL.4K^4_P7XAU#PCXO
M\+^*M(O)-/U7PUX@T?7M-OXG9)+*_P!'U"WU&RNT=2"K6]S;13 @C!2OY<S6
MA/@WC*?U1SC3R['X?&85<SYI8&OR5E0E)N\D\-5Q.%DY7YE"+E=W9_U1>%6>
M8/Z9_P!"S"+BZGA:^8^(?A_G_!_%%3V--4L/QSP^L9DTL\H48PY<-6AQ'E7#
MG%-"-&,/JU7&8JEA^2FX17];_P#P=)_M<GX6?LK> /V7/#>JFV\5?M#^)SK/
MBFWMYIXKF/X9^ I8+RXCE,2F)K?6O%=QHELT$[)Y\.GWACWB&1:_@6T/1]0\
M0ZSI.@:1:RWNJZWJ5CI.FV<"L\UW?ZC<Q6EG;1(H+-+/<31Q1JH)9W4 9-?I
MU_P6,_;=C_;O_;<\<_%/0KJ63X<^%]'\/_#OX;6K-.(H-#\/6"2ZQ>+#+(\8
MDU3Q;>Z_>">%4%Q9-8;]YB#GW+_@WQ_92_X:=_X*/?#'5=8TXWO@/]GJUN?C
MMXM:2-7M'U#PI<6MOX TV;S089&O/'=_H5\]HZR&ZTS2-5 C*1RR1_U7"473
MC.+O&<(U(OHXSC&47Z.,XOY]&?\ *U7P];!5L3A<1!T\1A,1B,+B*;:;IXC"
MUZ^%KTVXN46Z=?#5J;<92BW!N+::;_T%_P!@W]FK3_V0OV0?@%^SU9P0Q7WP
M]^'VCVOBB:%8O].\;ZJC:YXUOGFB&+D3>)]2U1;>=R[FSCMHPVR-%7ZYHHK,
MY#\5?^"^W[)O_#4W_!.CXISZ-I:7_CWX#F/XW^$'CMHIKXVGA*VN5\;Z?;RR
M?-!#=^#+G5[V<1$---I-FF"0!7^8URI]"#^1!K_:!U32].UO3-1T75[*WU'2
M=7L+O2]4T^\B6:TO].O[>2TO;*ZA<%);>ZMI98)XF!62)V1@037^2?\ \%$/
MV8]0_8[_ &T/V@OV?+J">+3? _C_ %-_"$\X(?4/ 7B$1^)/ VI9)(8W?A;5
M=+:;#-LN1/$S%XV-:0>Z^:_4T@]U\U^I_>=_P;H?M;G]I/\ X)]>%_ >O:D;
MWQ[^S5JLOPGUG[1<23WUSX6CB_M3P%J4SW$LEQ,HT2X;1!.WR%]$9 Q937[X
M5_G#_P#!MC^UPO[//[?-A\)_$&I"S\#?M1: _P .+H3,B6L'CS2FN-<^'UY+
M)+*B0FYO%U7PY%L1I9[KQ!:Q A<@_P"CQ4R5F_O)DK-_>%%%%22%?X^?[6__
M "=;^TW_ -G"?&C_ -61XEK_ &#*_P ?/]K?_DZW]IO_ +.$^-'_ *LCQ+6E
M/=^GZFE/=^GZG]5O_!H?_P A_P#;R_[ W[.'_I=\;Z_M?K^*#_@T/_Y#_P"W
ME_V!OV</_2[XWU_:_4S^)_+\B9_$_E^04445))_)W_P=J_\ )J7[+G_9PFK_
M /JM_$%?P;Q?ZU/]X5_>1_P=J_\ )J7[+?\ V<)K'_JM_$%?P;Q?ZU/]X5M#
MX?FS:'P_-G^SCX:_Y%SP_P#]@32O_2&WK;K$\,_\BYX?_P"P)I7_ *06];=8
MF(5_(5_P=Q?\D2_8U_[*G\4?_42\-U_7K7\A7_!W%_R1+]C7_LJ?Q1_]1+PW
M51^)>O\ F5'XEZ_YG\3WPO\ ^2E?#[_L=O"W_I\L:_V.O#'_ "+7A[_L!Z3_
M .D%O7^.+\+_ /DI7P^_[';PM_Z?+&O]CKPQ_P BUX>_[ >D_P#I!;U53I\_
MT*J=/G^AN5^4G_!<#_E%?^V)_P!DXMO_ %)]"K]6Z_*3_@N!_P HK_VQ/^R<
M6W_J3Z%4+=>J_,A;KU7YG^657ZH?\$C/^"<VO?\ !2/]J;3/AQ>W%]H_P@\!
MV5MXV^-GBJU9H[JQ\'V]Y#9VGAS1KAD>-/$?BZ]VZ/I.0396::IK/ER1:/)$
M_P"5]?Z*'_!K_P# +2_AI_P3QN?C$UI!_P )+^T3\4O%VOW6I! +IO"WP]U"
MY^'GA[29'VAC;V6L:-XNU. $G+ZW,X)1DQK)V7KH:R=EZZ'[[_"'X/\ PS^
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MK(\2U_L&5_CY_M;_ /)UO[3?_9PGQH_]61XEK2GN_3]32GN_3]3^JW_@T/\
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M^'W_ &.WA;_T^6-?['7AC_D6O#W_ & ])_\ 2"WJJG3Y_H54Z?/]#<K\I/\
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M6DA\%VZ_P#'TW_P=;_LAG4?#OP2_;4\,Z:#/H%PWP7^)]Q;P1*QTS47O-<\
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MB7C3%T4Z4,X\0>,:5>O+&8BCS2<*D,OK9OFM&A6<JN$I<09?3FU5A-G].?\
MP:[?LJ-\6?VR_%O[1>NZ6;CPI^S=X-FET>ZN+,36;_$;Q['>:#H<<5R7'V>^
MTW0(_$FJ1D*S92'H&)'^@[7X<?\ !O;^RH?V:/\ @G+\.-<UK2WT[QU^T->W
M7QL\2_:;?R+]-%UV&&Q\ 6,QP"]J/"%C8:[:!LLK>(KG+?,$3]QZ_29.[?W?
M<?YF2=V_N^X****DD**** /\NC_@N+^R2W[(W_!0[XS>'])TQM/\ _%+4?\
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MO]1/_@@Q_P HG_V1_P#L6O&O_JSO&E:5-EZ_H:5-EZ_H?K[11161D%?SS?\
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M/^"NG_*.3]JC_L0K,?B?%.@ #\3Q7Z/UQGQ"^'G@GXK^#=>^'GQ&\-:9XO\
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M/\BQ/OK_ +R_S%?ZS?\ P2Z_Y1W?L:_]D ^'W_IGAK\?O^(5/]@<<CXI_M(
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M9W0%RT3W<0N2+9DWR[DTEU3\K,3275/RLS^BNJ[WEI&YC>ZMDD4@,CSQ*X)
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M8'&Z]UW4K<9DLI-G]RE$W=V[?F$W=V[?F%%%%00%%%% !1110!_)Q_P=I_\
M)K?[+/\ V7O7O_4 U*OWE_X)G?\ */?]C'_LV_X3?^HAIE?@U_P=I_\ )K?[
M+/\ V7O7O_4 U*OWE_X)G?\ */?]C'_LV_X3?^HAIE4_ACZR_0I_#'UE^A^9
MO_!SC_RB\UW_ ++A\)O_ $9XAKX-_P""3/\ P7$_X)Z?LE_L"? ?X!?&GXB^
M-M%^)7@2S\7P^)-+TGX7>,_$%A:R:OXY\1Z[8B#5M+TV:QNUDT[4[21S!*_E
MRM)$^&0BOO+_ (.<?^47FN_]EP^$W_HSQ#7@/_!&W_@E=_P3Y_:(_P""<O[.
MWQ=^,_[+_@7QY\2?%6G^-'\2>+=5U/QG#J&L2Z=\0O%6EV4MU%IWB>SL4>WT
MZSM+-!:VEO&8K:-F1I3))(:<NM_B>UNR[AIRZW^)[6[+N?L;^Q-_P4\_9&_X
M*#:IX]T?]F7QAXF\3WWPVL-%U/Q7'X@\#^(_""VEIX@N+ZUTR2VDUVSM5O6E
MFTZ[61+<NT(0-( '4G^3C]CGPM9_\%%O^#BGXT_$;XK1?\)5X-^$/C_XI>/=
M*T+672XM1H7P<U*W\ _"719+&\1XI]/TB^_X1C4+JP-OY4\EG<-)$HN)G7^Q
M7]FG]A#]D;]CO4?%>K?LT? [PK\)-2\<66EZ=XKO/#UUX@NI];L=%GO+K2[6
MZ;7-9U7;%97%_>2PK (?GN)"Q;(Q_&__ ,$]O&=C^PE_P<,_'CX5_%N[@\.:
M;\3OB'\9_A18:YK2"VBD?XB^(+?QY\*]2\YRD5I;>,O)\,16MS*1"J:_;B1U
M0LX%:TK=M+]NNW4%:TK=M+]NNW4_O7HHHJ23^5#_ (.Q>/V1_P!G/_LN^H?^
MH5J5;'[#'_!?W_@FI\"_V.?V9O@Y\0_B;X^T[QU\-/@QX#\&>+=/L?A)XYU6
MTL]?T'0K2PU*WMM2LM,EL[Z&*YBD6.YMI9(9E =&(-8__!V+S^R/^SG_ -EW
MU#_U"M2KZ:_X)^_\$A/^";/Q8_8A_94^)?Q"_9,^'_B;QSXY^!7PY\2^+/$-
MYJGCB.[UO7M5\.65SJ6J74=KXK@MDN+VY>2XF6W@@@61V$,,485%O3E5[[O:
MWZEZ<JO?=[6_4Y?XX?\ !Q5_P2Y\<_!?XN>"O#_Q3^(EQKWB[X9>._#.B6\W
MP<\?6L,^KZ[X8U32]-AEN9]*6&WBDO+J%9)YF6.)"SNP"FOA3_@T;_Y%?]M+
M_L.?!_\ ](?'-?KQ\?O^",7_  2_\)_ KXS^*?#_ .Q[\.M.U[PY\*?B%KNB
MZA%JWCUI;#5M)\):M?Z=>Q+)XO>,RVMW!#/&)$="\8#HRY4_D/\ \&C?_(K_
M +:7_8<^#_\ Z0^.:-.5VONM[?H&G*[7W6]OT/ ?^"Q<%M=?\'!/[)-K>VMO
M>V5UJW[*%K>65W$D]I>6EQX_:&YM+J"0-'-;W,#O#/$ZE)(G9&!!-<!^UY\-
M/B#_ ,$!O^"I_@W]J+X+Z3?S?LJ_&?6=4U&'POIR30Z/-X/UJZ@?XE?!NZ>1
MI+)+_P -3SQ^(? K220216D>A&-5CT_46?T/_@L+_P K"'[(?_8<_9*_]6&*
M_J__ ."B7[$?@3]O_P#9:^('P \8):6.LZC9OKGPV\736R37/@GXBZ5!-)X<
MUR!]IF6REG=M+UV"$AKS0[Z_MP#(T3(7LH]G&S]+O\@O91[.-GZ7?Y')?M?_
M !3\"_&__@E]^T?\7?AGKUIXG\ _$7]DGXF^*_"FNV3!H-0TC5OA_J]Q;N1D
MF&XA+/;7EM)B6TO(9[:95EB=1^&W_!I/_P FZ?M:?]EG\%_^H7<U^9?[ /[:
MGCG]F#X!?\%#_P#@DM^U=-=>$]7TWX/?M#0?!F'Q).8F\/?$S3O"NMQ^)_A=
M:23D+)IGCA0_BKP:\+&UN=4CU!;(W!\3V 'Z:?\ !I/_ ,FZ?M:?]EG\%_\
MJ%W-*UE+UC9]UJ*UE+UC9]UJ?!?_  0V\+:;^VW_ ,%FOVEOVI?BM:IKNK>
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M*UU>ZM?:VI?_ &L?^5I+X.?]E*^!/_JL=.K]J_\ @Y6_Y14?$_\ [*;\&_\
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MQ')?:U C6EJF@6/^F:J9WC^SV_SKYC96O[$***&[V\E8&[V\E8_E!_X.*O\
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MCJ73K6.VN]LEI%=^1$+J/Q+I]I8NO][5%-2M?1-/H]AJ5KZ)I]'L?Q)^(_\
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M5?"[X/>,?C1^R1\0OBAJGCKP-H?B7P5KGQ4^'MEI&LVEI+*OAK7O!M['XE\
MWSR17=Q=^'1J5KIT5^[WMSH%W-),\WB_Q(_X+<?\%<_VQO ?B#X%_L]?L&ZK
MX"\1^/\ 0]3\(:OXL\+^!_B7XO\ $5I9ZE;7&FZZ?#TWB#3=*\.^';UK6>2
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
IHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>biaf-20250306.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaCMibP9z5Z8GekhvWB4bTl6byIhkurE1Cvp/GS2cV4O -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:BIAF="http://bioaffinitytech.com/20250306" elementFormDefault="qualified" targetNamespace="http://bioaffinitytech.com/20250306">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://bioaffinitytech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250306_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250306_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="biaf-20250306_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="BIAF_CommonStockParValue0.007PerShareMember" name="CommonStockParValue0.007PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="BIAF_WarrantsToPurchaseCommonStockMember" name="WarrantsToPurchaseCommonStockMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>biaf-20250306_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bioaffinitytech.com/role/Cover" xlink:href="biaf-20250306.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_CommonStockParValue0.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue0.007PerShareMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue0.007PerShareMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_WarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFWarrantsToPurchaseCommonStockMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFWarrantsToPurchaseCommonStockMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_40" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_40" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_40" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_40" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_40" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_40" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_40" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_40" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_40" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_40" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_40" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_40" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_40" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_40" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_40" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_40" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_40" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_40" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_40" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_40" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_40" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_40" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_40" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_40" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_40" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_40" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_40" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_40" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_40" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_40" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_40" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_40" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_40" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_40" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_40" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_40" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_40" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_40" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_40" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_40" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_40" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_40" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_40" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_40" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_40" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_40" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_40" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_40" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_40" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_40" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_40" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_40" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_40" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_40" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>biaf-20250306_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_CommonStockParValue0.007PerShareMember" xlink:label="BIAF_CommonStockParValue0.007PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_CommonStockParValue0.007PerShareMember" xlink:to="BIAF_CommonStockParValue0.007PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_CommonStockParValue0.007PerShareMember_lbl" xml:lang="en-US">Common Stock, par value $0.007 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_WarrantsToPurchaseCommonStockMember" xlink:label="BIAF_WarrantsToPurchaseCommonStockMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="BIAF_WarrantsToPurchaseCommonStockMember" xlink:to="BIAF_WarrantsToPurchaseCommonStockMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="BIAF_WarrantsToPurchaseCommonStockMember_lbl" xml:lang="en-US">Warrants to purchase Common Stock</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>biaf-20250306_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://bioaffinitytech.com/role/Cover" xlink:href="biaf-20250306.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://bioaffinitytech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_CommonStockParValue0.007PerShareMember" xlink:label="loc_BIAFCommonStockParValue0.007PerShareMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFCommonStockParValue0.007PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="biaf-20250306.xsd#BIAF_WarrantsToPurchaseCommonStockMember" xlink:label="loc_BIAFWarrantsToPurchaseCommonStockMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_BIAFWarrantsToPurchaseCommonStockMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm45788970097392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 06, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  06,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-41463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">bioAffinity
Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001712762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-5211056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3300
Nacogdoches Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite
216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San
Antonio<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">78217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-5334<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue0.007PerShareMember', window );">Common Stock, par value $0.007 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
                                            Stock, par value $0.007 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAF<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=BIAF_WarrantsToPurchaseCommonStockMember', window );">Warrants to purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants
    to purchase Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BIAFW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue0.007PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_CommonStockParValue0.007PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=BIAF_WarrantsToPurchaseCommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=BIAF_WarrantsToPurchaseCommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M'LPXO=D5VYQ8E>8[40MEK4KRPX@S:)/N ;B_5,J^GKC-K6)O<O0?4$L#!!0
M   ( "BF9EK@]#J)J@(  # ,   -    >&PO<W1Y;&5S+GAM;.U7VXK;,!#]
M%:$/J).X-7%) FT@4&C+PNY#7Y58=@2ZN+*<.OOUU5BV<UG-]O)8ZI!X9HYF
MYHQF9)-5X\Z2/QXY=Z134C=K>G2N?I\DS>'(%6O>F)IKCY3&*N:\:JNDJ2UG
M10-.2B:+V2Q+%!.:;E:Z53OE&G(PK79K.J/)9E4:?;&D-!C\4J8X.3&YIELF
MQ=Z*?BU30IZ#>0&&@Y'&$N>I\#6=@Z5Y#O \:,!RB*.$-A:,2<@0?O?#\CM@
MU!JO"BDG@@L:#)M5S9SC5N^\TB_NC2\@,LA/Y]HSK"P[SQ?OZ,6AO_DD>V,+
M;J<T<SJ:-BO)2Z!C176$NS-U J!S1GFA$*PRFO4<1H]!\&$/7,I':.&W\B9V
M5Y+0BT\%M(% J:/H"0UB"!,4B'\=+<2^"OOVK\*26IR,^]CZ:G2O?V^-XP^6
MEZ+K]:Z<\F/1YWAT5M?R_$&*2BL>:O_MA)L5&_W(T5CQ[+/!I!R\@5M*3MPZ
M<;BV_+"L?N*=&Z>I*W'.B_^<?\&YXII;)J])^]&/,TZ&6;P:^)MQGZP$'BMK
M^A6>5O+"@>Q;(9W0@W841<'UBZGWX1W;^\?A37R_ON E:Z5[FL UO<A?>"%:
ME4^K'F!?AE47^3.<[GDV/=-\+J$+WO%B.ZBVVO<B\8+/.ES@<(_L^BN.8#X!
MBR. 87DP!IA/\,+R_$OU+-%Z H9Q6T:1)>JS1'V"5PS9]A\L3]PG]U>\TCQ/
MTRS#=G2[C3+88ON69?"-1\.X@0>6!S+]V5[CW<8GY/4YP'KZVH1@E>*3B%6*
M[S4@\7T#CSR/=QO+ QY8%[#9@?SQ/#!3<9\TA:YBW+ 3C"-YCB$PB_$9S3)D
M=S+XQ/N#G9(TS?,X EB<09IB")Q&',$8  <,2=/^/7CW/DK&]U1R^8^P^0E0
M2P,$%     @ **9F6I>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#
M, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5QD L9>3T\$MP>:4#M
M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC0[!:+#Y +AEFM[UD
M%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3
MY?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ:%0*CMQC)8QQ8K3^
M-8+)#^Q^ %!+ P04    "  HIF9:JL0B%C,!   B @  #P   'AL+W=O<FMB
M;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4(HDKQX6-KY_;
MJAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q
M8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P.6/$ SJ4[]ST
M=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7F?RTA]@S8@\?
M5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#B
MG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMRR"9JZJ8IGJ,.
M>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48<?R>Y0]0
M2P,$%     @ **9F6B0>FZ*M    ^ $  !H   !X;"]?<F5L<R]W;W)K8F]O
M:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C$A+%K@JW+X4!
MD#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&
MO-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S"
M:+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X
M=/X!4$L#!!0    ( "BF9EIED'F2&0$  ,\#   3    6T-O;G1E;G1?5'EP
M97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*
MH!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJU
MDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7
MQ<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!Z
MVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$
M?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECFS_A[QA?_&\[Q
M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ **9F6@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  HIF9:5ZS*W>\    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  HIF9:F5R<(Q &  "<)P  $P
M    @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( "BF9EJE
M3P-OY00  *<4   8              " @0X(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  HIF9:X/0ZB:H"   P#   #0
M    @ $I#0  >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( "BF9EJ7BKL<P
M !,"   +              "  ?X/  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M "BF9EJJQ"(6,P$  "("   /              "  ><0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  HIF9:)!Z;HJT   #X 0  &@
M@ %'$@  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  H
MIF9:99!YDAD!  #/ P  $P              @ $L$P  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  !V%      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://bioaffinitytech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>biaf-20250306.xsd</File>
    <File>biaf-20250306_def.xml</File>
    <File>biaf-20250306_lab.xml</File>
    <File>biaf-20250306_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="27">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "BIAF",
   "nsuri": "http://bioaffinitytech.com/20250306",
   "dts": {
    "schema": {
     "local": [
      "biaf-20250306.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "biaf-20250306_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "biaf-20250306_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "biaf-20250306_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 65,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 27
   },
   "report": {
    "R1": {
     "role": "http://bioaffinitytech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-03-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-03-06",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "auth_ref": []
    },
    "BIAF_CommonStockParValue0.007PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20250306",
     "localname": "CommonStockParValue0.007PerShareMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock, par value $0.007 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "BIAF_WarrantsToPurchaseCommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://bioaffinitytech.com/20250306",
     "localname": "WarrantsToPurchaseCommonStockMember",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants to purchase Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://bioaffinitytech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001493152-25-009452-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-009452-xbrl.zip
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M_0_>['/(!\W,-M/L5$C#5&JZFRQANG?WA5)L)5&A2"E)AN3?C^2/8,>ZML.
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M*1)10=@_Z?=_GF(Q6R&!OR8SPX(Y)KI>\!NXE9^U DZ4' G\13F (]I+AS3
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M2LX9I\37"K'E5YV'((C:-2_B&BTX0!=4VU%U.171HQ)83_*CQ7#FH5UQLUA
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MC"K1GJ[/TET60#)_]_R1+ B7ZP[NR#9[)P[TT'*%T2/6]=5;[^J8%W.=@4%
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MRS0^II[;P=:L: 6%C9O.^M2A0,YO9@CCEJ&$0.];0F'C9K$AE2C >]9A1?A
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M#0NH[K8^T@ <D@5P;4/C*H#G%OH]N>52<F=6 ZF2L/DO,/0ETYG1#J?0^S^
M0RJ$Q!\^P[9)]>#0B0[M<PW\D]\,'B3Y'M+\L%VXJ%7/*^58Z[QX7FD=IMI
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M]#@;NEY+G]X8&./T?8<0-P//4ORK#\ IL09ZPD(7R>D!U%U0R%O\ ZP1P9G
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M!]J$*'1@B_W*^[==W<UY&]"%RKAY 6"T68]J'7]_65QT[%7 S<\!;EZ+(>C
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M\&?/Z6N%_P-02P$"% ,4    "  HIF9:[9O1\\P#  #8#@  $0
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M(0  97@Y.2TQ+FAT;5!+ 0(4 Q0    ( "BF9EILT?L\OA<  "?!   +
M          "  7PR  !F;W)M."UK+FAT;5!+!08     !@ & 'D!  !C2@
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:BIAF="http://bioaffinitytech.com/20250306"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="biaf-20250306.xsd" xlink:type="simple"/>
    <context id="AsOf2025-03-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
        </entity>
        <period>
            <startDate>2025-03-06</startDate>
            <endDate>2025-03-06</endDate>
        </period>
    </context>
    <context id="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:CommonStockParValue0.007PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-06</startDate>
            <endDate>2025-03-06</endDate>
        </period>
    </context>
    <context id="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001712762</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">BIAF:WarrantsToPurchaseCommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-03-06</startDate>
            <endDate>2025-03-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-03-06" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-03-06" id="Fact000004">0001712762</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-03-06" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-03-06" id="Fact000010">2025-03-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-03-06" id="Fact000011">bioAffinity Technologies, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-03-06" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-03-06" id="Fact000013">001-41463</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-03-06" id="Fact000014">46-5211056</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-03-06" id="Fact000015">3300 Nacogdoches Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-03-06" id="Fact000016">Suite 216</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-03-06" id="Fact000017">San Antonio</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-03-06" id="Fact000018">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-03-06" id="Fact000019">78217</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-03-06" id="Fact000020">(210)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-03-06" id="Fact000021">698-5334</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-03-06" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-03-06" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-03-06" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-03-06" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember"
      id="Fact000026">Common                                             Stock, par value $0.007 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember"
      id="Fact000027">BIAF</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-03-062025-03-06_custom_CommonStockParValue0.007PerShareMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000029">Warrants     to purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000030">BIAFW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-03-062025-03-06_custom_WarrantsToPurchaseCommonStockMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-03-06" id="Fact000032">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2025-03-06" id="Fact000033">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
